Mutation Information
Mutation Site
|
T215rev |
Mutation Type
|
Amino acid level |
Gene/Protein/Region Type
|
RT |
Literature Information
PubMed PMID
|
30544247
|
Disease
|
HIV infection/AIDS
|
Published Year
|
2019 |
Journal
|
The Journal of antimicrobial chemotherapy |
Title
|
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance. |
Author
|
Geretti AM,White E,Orkin C,Tostevin A,Tilston P,Chadwick D,Leen C,Sabin C,Dunn DT,UK HIV Drug Resistance Database and UK CHIC Study. |
Evidence
|
There were 203 of 269 (75.5%) subjects with singleton TAMs, most commonly T215rev (112 of 269, 41.6%); a smaller subset harboured two (n = 52, 19.3%) or three (n = 14, 5.2%) TAMs.
|
|
|